Tumour necrosis factor-α promoter polymorphisms in primary biliary cirrhosis

Journal of Hepatology

Volumn 30, Issue 2, 1999, Pages 232-236

  Jones, David E J ^a   Watt, Fiona E ^a   Grove, Jane ^a   Newton, Julia L ^a   Daly, Anne K ^a   Gregory, Wendy L ^a   Day, Christopher P ^a   James, Oliver F W ^a   Bassendine, Margaret F ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Biliary; Cytokines; HLA DR8; Immunogenetics; Liver cirrhosis; MHC class II; Tumour necrosis factor

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; DNA DETERMINATION; DNA POLYMORPHISM; GENE FREQUENCY; GENETIC PREDISPOSITION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; PROMOTER REGION;

EID: 0032909904     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(99)80067-1     Document Type: Article

References (44)

1. Kaplan M. Primary biliary cirrhosis. N Engl J Med. 335:1996;1570-1579.
2. Chohan MR. Primary biliary cirrhosis in twin sisters. Gut. 14:1973;213-214.
3. Bach N, Schaffner F. Familial primary biliary cirrhosis. J Hepatol. 20:1994;698-701.
4. Brind AM, Bray GP, Portmann BC, Williams R. Prevalence and pattern of familial disease in primary biliary cirrhosis. Gut. 36:1995;615-617.
5. Gores GJ, Moore SB, Fisher LD, Powell FC, Dickson ER. Primary biliary cirrhosis: associations with class II major histocom-patibility antigens. Hepatology. 7:1987;889-892.
6. Manns MP, Bremm A, Scheider PM, Notghi A, Gerken G, Prager-Eberle M, et al. HLA-DRw8 and complement C4 deficiency as risk factors in primary biliary cirrhosis. Gastroenterology. 101:1991;1367-1373.
7. Underhill J, Donaldson P, Bray G, Doherty D, Portmann B, Williams R. Susceptibility to primary biliary cirrhosis is associated with the HLA-DR8-DQB1*0402 haplotype. Hepatology. 16:1992;1404-1408.
8. Gregory WL, Mehal W, Dunn AN, Cavanagh G, Chapman R, Fleming KA, et al. Primary biliary cirrhosis: contribution of HLA class II allele DR8. Q J Med. 86:1993;393-399.
9. Onishi S, Sakamaki T, Maeda T Iwamura S, Tomita A, Saibara T, et al. DNA typing of HLA class II genes; DRB1*0803 increases the susceptibility of Japanese to primary biliary cirrhosis. J Hepatol. 21:1994;1053-1060.
10. Briggs DC, Donaldson PT, Hayes P, Welsh KI, Williams R, Neuberger JM. A major histocompatibility complex class III allotype (C4B2) associated with primary biliary cirrhosis (PBC). Tissue Antigens. 29:1987;141-145.
11. Weissman SM. Genetic bases for common polygenic diseases. Proc Natl Acad Sci USA. 92:1995;8543-8544.
12. Gregory WL, Daly AK, Dunn AN, Cavanagh G, Idle JR, James OFW, et al. Analysis of HLA-class-II-encoded antigen-processing genes TAP1 and TAP2 in primary biliary cirrhosis. Q J Med. 87:1994;237-244.
13. Mehal WZ, Gregory WL, Lo Y-MD, Cross SJ, Fleming KA, Bassendine MF, et al. Defining the immunogenetic suceptibility to primary biliary cirrhosis. Hepatology. 20:1994;1213-1219.
14. Begovich AB, Klitz W, Moonsamy PV, Van de Water J, Peltz G, Gershwin ME. Genes within HLA class II region confer both predisposition and resistance to primary biliary cirrhosis. Tissue Antigens. 43:1994;71-77.
15. Mella JG, Roschmann E, Maier KP, Volk BA. Association of primary biliary cirrhosis with the allele HLA-DPB1*0301 in a German population. Hepatology. 21:1995;398-402.
16. Underhill JA, Donaldson PT, Doherty DG, Manabe K, Williams R. HLA DPB polymorphism in primary sclerosing cholangitis and primary biliary cirrhosis. Hepatology. 21:1995;959-962.
17. Zappala F, Grove J, Watt FE, Daly AK, Day CP, Bassendine MF, et al. No evidence for involvement of the interleukin-10 promoter polymorphism in genetic susceptibility to primary biliary cirrhosis. J Hepatol. 28:1998;820-823.
18. Spengler U, Moller A, Jung MC, Messer G, Zachoval R. T lymphocytes from patients with primary biliary cirrhosis produce reduced amounts of lymphotoxin, tumour necrosis factor and interferon-gamma upon mitogen stimulation. J Hepatol. 15:1992;129-135.
19. Broome U, Eriksson LS, Sundin U, Sundqvist KG. Decreased in vitro production of tumour necrosis factor in primary biliary cirrhosis. Scand J Gastroenterol. 27:1992;124-128.
20. Gressner AM. Mediators of hepatic fibrogenesis. Hepatogastro-enterology. 43:1996;92-103.
21. Bodmer JG, Marsh SGE, Albert ED, Bodmer WF, Bontrop RE, Charron D, et al. Nomenclature for factors of the HLA system, 1996. Hum Immunol. 53:1996;98-128.
22. Fugger L, Morling N, Ryder LP, Platz P, Georgsen J Jakobsen BK, et al. Nco I restriction length fragment polymorphism (RFLP of the tumour necrosis factor (TNFα) region in primary biliary cirrhosis and in healthy Danes. Scand J Immunol. 30:1989;185-189.
23. Messer G, Spengler U, Jung MC, Honold G, Eisenburg J, Scholz S, et al. Allelic variation in the TNF-β gene does not explain the low TNF-β response in patients with primary biliary cirrhosis. Scand J Immunol. 34:1991;735-740.
24. Wilson AG, de Vries N, Pociot F, di Giovine FS, van der Putte LBA, Duff GW. An allelic polymorphism within the human tumour necrosis factor α promoter region is strongly associated with HLA A1, B8, and DR3 alleles. J Exp Med. 177:1993;557-560.
25. D'Alfonso S, Richiardi PM. A polymorphic variation in a putative regulation box of the TNF alpha promoter region. Immunogenetics. 39:1994;150-154.
26. Danis VA, Millington M, Hyland V, Lawford R, Huang C, Grennan D. Increased frquency of the uncommon allele of tumour necrosis factor alpha gene polymorphism in rheumatoid arthritis and systemic lupus erythematosus. Disease Markers. 12:1995;127-133.
27. Wilson AG, Gordon C, di Giovine FS, de Vries N, van der Putte LBA, Emery P, et al. A genetic association between systemic lupus erythematosus and tumour necrosis factor alpha. Eur J Immunol. 24:1994;191-195.
28. Manus RM, Wilson AG, Mansfield J, Weir DG, Duff GW, Kelleher D. TNF2, a polymorphism of the tumour necrosis factor-alpha gene promoter, is a component of the coeliac disease major histocompatibility complex haplotype. Eur J Immunol. 26:1996;2113-2118.
29. Wilson AG, Symons JA, McDowell TL, McDevitt HO. Effects of a polymorphism in the tumor necrosis factor α promoter on transcriptional activation. Proc Natl Acad Sci USA. 94:1997;3195-3199.
30. Brinkman BMN, Zuijdgeest D, Kaijzel EL, Breedveld FC, Verweij CL. Relevance of the tumor-necrosis-factor-alpha (TNF-alpha) -308 promoter polymorphism in TNF-alpha gene regulation. J Inflamm. 46:1996;32-41.
31. Hohler T, Kruger A, Gerken G, Scheider PM, Meyer zum Büschenfelde K-H, Rittner C. A TNF-alpha promoter polymorphism is associated with chronic hepatitis B. [abstract] J Hepatol 1997; 26: 68.
32. Pociot F, D'Alfonso S, Compasso S, Scorza R, Richiadi PM. Functional analysis of a new polymorphism in the human TNF α gene promoter. Scand J Immunol. 42:1995;501-504.
33. Scheuer PJ. Primary biliary cirrhosis. Proc R Soc Med. 60:1967;1257-1260.
34. Grove J, Daly AK, Bassendine MF, Day CP. Association of a tumor neerosis factor promoter polymorphism with susceptibility to alcoholic steatohepatitis. Hepatology. 26:1997;143-146.
35. Jones DEJ, James OFW, Bassendine MF. Primary biliary cirrhosis: clinical and associated autoimmune features and natural history. Clin Liver Dis. 2:1998;711-718.
36. Metcalf JV, Mitchison HC, Palmer JM, Jones DEJ, Bassendine MF, James OFW. Natural history of early primary biliary cirrhosis. Lancet. 348:1996;1399-1402.
37. Locke GR, Therneau TM, Lidwig J, Dickson ER, Lindor KD. Time course of histological progression in primary biliary cirrhosis. Hepatology. 23:1996;52-56.
38. Sherlock S, Scheuer PJ. The presentation and diagnosis of 100 patients with primary biliary cirrhosis. N Engl J Med. 289:1973;674-678.
39. Metcalf JV, Bhopal RS, Gray J, Howel D, James OFW. Incidence and prevalence of primary biliary cirrhosis in the city of Newcastle upon Tyne, England. Int J Epidemiol. 26:1997;830-836.
40. Gordon MA, Gleeson D, Oppenheim E, di Giovine FS, Camp NC, Duff GW. Tumour necrosis factor genetic polymorphisms and primary biliary cirrhosis. [abstract] Hepatology 1996; 24: 166A.
41. Smith BC, Grove J, Guzail MA, Day CP, Daly AK, Burt AD, et al. Heterozygosity for haemochromatosis is associated with more fibrosis in chronic hepatitis C. Hepatology. 27:1998;1695-1699.
42. Wilhelmsen KC. Does tumor necrosis factor play a role in alcoholic steatohepatitis? The potential pitfalls of a case controlled allelic association study. Hepatology. 26:1997;232-233.
43. Spiclman R, McGinnis R, Ewens W. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet. 52:1993;506-516.
44. Spielman RS, Ewens WJ. The TDT and other family-based tests for linkage disequilibrium and association. Am J Hum Genet. 59:1996;983-989.